Korea Drug Development Fund to conclude joint anticancer R&D agreement
The Korea Drug Development Fund(Head Sang-Un Joo, hereinafter referring to KDDF) will start the ‘BigPharma Joint R&D Program’ in regards of anticancer development researches.
On the 8th, the KDDF announced it concluded the MOU to operate the joint R&D program with a global pharmaceutical compan...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
